Sanofi has agreed to buy US biotech firm Inhibrx in a deal valued at up to $2.2bn, bolstering its drug development portfolio with an experimental treatment for a rare genetic disease. Under the terms of the agreement, Sanofi…

    Bora Pharmaceuticals, a contract development and manufacturing organization (CDMO), has officially acquired Upsher-Smith Laboratories, a specialty-brand and generics company, for $210 million. Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48…